This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Catherine Warren is Vice President of Strategic Partnerships at Arch Amenities Group, a provider of comprehensive amenity management and consulting services for hotels, residential complexes, and commercial real estate. Moreover, I’m excited about the prospect of scaling our impact through education and training initiatives.
As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio. Under the mentorship of Susan Harmsworth, she honed her skills in areas like spa therapies, aromatherapy, wellness operations, design, marketing, and public relations.
market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. In February 2023, Fresenius Kabi and Formycon entered into a global commercialization partnership for the ustekinumab biosimilar candidate covering key global markets. and worldwide.
Additionally, look into your market and similar practices in the area, which will be your competition. The program aims to help you pinpoint your personal business goals, allowing you to transition to and succeed in the aesthetic medicine field. Further, compare a few insurance policies to ensure you’re covered.
“China has always been a strategic market for Sisram, and the approval of Daxxify serves as a key milestone for bringing Sisram’s high-end injectables portfolio to Mainland China,” says Mr. Liu Yi, Sisram Chairman and Executive Director, in a news release.
Managing an extensive portfolio of more than 120 hotels, including 26 major brands and 19 boutique properties, Remington has positioned itself as a leader in the hospitality industry. Remington also places a strong emphasis on innovation and adapting to market trends. I am also excited about new openings and partnerships.
“We are increasingly optimistic about the near-term potential that the next-generation technology in the Evolysse and Estyme fillers lines will offer customers in the fast-growing facial HA market. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K. to now include the U.K.
“We are increasingly optimistic about the near-term potential that the next-generation technology in the Evolysse and Estyme fillers lines will offer customers in the fast-growing facial HA market. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K. to now include the U.K.
Moreover, Glenmark Pharmaceuticals received manufacturing and marketing approval for the Nitric Oxide Nasal Spray (NONS) as part of an accelerated approval process. Glenmark Pharmaceuticals has signed a partnership with Canadian company SaNOtize Research & Development Corp., You can purchase it online on Amazon.com.
It’s what happens when expertise meets market needs. Initially, you might work on models or offer your services at a reduced rate to build a portfolio. Remember, marketing your new skills is crucial. Update your website, social media, and other marketing materials to reflect your new services. This is common.
We are thrilled to announce this agreement with Kaken, a dermatology leader with significant reach and expertise in the Japanese market, says Martin Babler, President and Chief Executive Officer of Alumis, in a news release. ESK-001 will be an important addition to the Kaken portfolio of novel therapeutics for dermatology conditions.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content